In This Article:
Forian (NASDAQ:FORA) Third Quarter 2024 Results
Key Financial Results
-
Revenue: US$4.69m (down 12% from 3Q 2023).
-
Net loss: US$204.9k (down by 104% from US$5.45m profit in 3Q 2023).
-
US$0.007 loss per share (down from US$0.17 profit in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Forian EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) exceeded analyst estimates by 67%.
Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 9.7% growth forecast for the Healthcare Services industry in the US.
Performance of the American Healthcare Services industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
You should learn about the 3 warning signs we've spotted with Forian.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.